8.484.61% ( -0.41 )
Delay Closed: Nov 13, 15:00:00Valuation
Current ValuationThe current P/E ratio is 14.78, within the reasonable range, cheaper than 51.92% of the time in the past 5 years, and the industry ranks 3/65, the industry Median 27.64.
14.78xP/E
¥8.48Stock price
¥0.57Earnings per share
14.78xP/E
Stock price¥8.48Earnings per share¥0.57
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 15.03x
- Typical range
- -25.76x–18.04x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 27.64x
014284256
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 27.64x
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
002432SZANDON HEALTH | 4.39x | -- | ¥25.84B |
300358SZTruking | 14.78x | 14.89% | ¥6.06B |
603387SHGetein Biotech | 14.29x | -- | ¥4.18B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
